Listar Technical documents and research evidence on COVID-19 por título
Mostrando ítems 869-888 de 1749
-
Interim Guidance for Businesses and Employers to Plan and Respond to Coronavirus Disease 2019 (COVID-19) Plan, Prepare and Respond to Coronavirus Disease 2019
Purpose: This interim guidance is based on what is currently known about the coronavirus disease 2019 (COVID-19). COVID-19 is a respiratory illness that can spread from person to person. The outbreak first started in China, ... -
Interim Guidance for COVID-19 and Persons with HIV
(2020-03-20)This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19. Information and data on COVID-19 are rapidly evolving. This guidance includes ... -
Interim guidance for the poliomyelitis (polio) surveillance network in the context of coronavirus disease (COVID-19), 4 June 2020
(2020-06-04)This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the ... -
Interim guidance on continuity of immunization programs during the COVID-19 pandemic
(2020-05-13)Preamble: As a public health emergency of international concern, the coronavirus disease 2019 (COVID-19) pandemic (caused by the novel SARS-CoV-2 virus) has already impacted many aspects of healthcare delivery. Within ... -
Interim guidance: Management of mass fatalities during the coronavirus disease (COVID-19) pandemic
(2020-05-04)The Public Health Agency of Canada, in collaboration with Canadian public health and infection prevention and control (IPC) experts and the Funeral Services Association of Canada, has developed this guidance on public ... -
Interim laboratory biosafety guidelines for the handling and transport of samples associated with the novel coronavirus 2019 (2019-nCoV), 28 January 2020
(2020-01-28)In January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as a novel beta-coronavirus (2019-nCoV), distinct than SARS-CoV and MERS-CoV (1) (2) (3). The complete ... -
An international randomised trial of candidate vaccines against COVID-19
(2020-04-09)Summary: Recognizing the critical importance to world health of the rapid availability and deployment of effective vaccines against COVID-19, this large, international, multi-site, individually randomized controlled clinical ... -
Interpretation of laboratory results for COVID-19 diagnosis, 6 May 2020
(2020-05-06)Etiological confirmation of COVID-19 virus (SARS-CoV-2) infection can only be made by laboratory tests. In general, the currently available assays for COVID-19 can be classified into two groups: • The first group (virological ... -
Interventions for Children, Youth, and Parents to Prevent and Reduce Cyber Abuse
(2009-06-05)This Campbell Systematic Review examines the effectiveness of cyber abuse interventions in increasing internet safety knowledge and decreasing risky online behaviour. The review summarises findings from three studies: ... -
Interventions for people with disabilities in low‐and middle‐income countries: evidence and gap map
(2020-07-16)Citation: Saran A, White H, Kuper H. Evidence and gap map of studies assessing the effectiveness of interventions for people with disabilities in low‐and middle‐income countries. Campbell Systematic Reviews. 2020;16(1):e1070. ...